Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Nowrousian

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Deutsche Medizinische Wochenschrift (1946)|November 16, 1973
[Significance and reliability of various tests of thyroid function in medical practice (author's transl)]D Emrich, U Schulz, zur Mühlen A von, et al.
Haematology and Blood Transfusion|January 1, 1980
Autologous bone marrow transplantation. The influence of prolonged cytotoxic chemotherapyU W Schaefer, M R Nowrousian, S Ohl, et al.
Deutsche Medizinische Wochenschrift (1946)|July 20, 1999
[Antimicrobial therapy for fever of unknown origin in neutropenia. Standard recommendations of the Work Group of Infections in Hematology and Oncology of the German Association of Hematology and Oncology]H Link, K Blumenstengel, A Böhme, et al.
Deutsche Medizinische Wochenschrift (1946)|August 17, 1990
[Chemotherapy of nonendemic Burkitt's lymphoma]R Kath, K Höffken, K Günzel, et al.
Leukemia|January 28, 2005
Cellular in vitro immune function in multiple myeloma patients after high-dose chemotherapy and autologous peripheral stem cell transplantationM Lindemann, P Schuett, T Moritz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 1999
Gemcitabine as a single agent in the treatment of relapsed or refractory aggressive non-Hodgkin's lymphomaA Fosså, A Santoro, W Hiddemann, et al.
European Journal of Haematology|February 23, 2007
Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomasP Schütt, J Passon, P Ebeling, et al.
Blut|June 18, 1979
[Effect of long-term cytostatic therapy on the hematopoietic stem cells]M R Nowrousian, U W Schaefer, S Ohl, et al.
British Journal of Haematology|October 1, 1995
Homozygous loss of the MTS1/p16 and MTS2/p15 genes in lymphoma and lymphoblastic leukaemia cell linesR Siebert, C P Willers, A Schramm, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2003
Impact of chemotherapy regimen and hematopoietic growth factor on mobilization and collection of peripheral blood stem cells in cancer patientsM R Nowrousian, S Waschke, P Bojko, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Deutsche Medizinische Wochenschrift (1946)|November 16, 1973
[Significance and reliability of various tests of thyroid function in medical practice (author's transl)]D Emrich, U Schulz, zur Mühlen A von, et al.
Haematology and Blood Transfusion|January 1, 1980
Autologous bone marrow transplantation. The influence of prolonged cytotoxic chemotherapyU W Schaefer, M R Nowrousian, S Ohl, et al.
Deutsche Medizinische Wochenschrift (1946)|July 20, 1999
[Antimicrobial therapy for fever of unknown origin in neutropenia. Standard recommendations of the Work Group of Infections in Hematology and Oncology of the German Association of Hematology and Oncology]H Link, K Blumenstengel, A Böhme, et al.
Deutsche Medizinische Wochenschrift (1946)|August 17, 1990
[Chemotherapy of nonendemic Burkitt's lymphoma]R Kath, K Höffken, K Günzel, et al.
Leukemia|January 28, 2005
Cellular in vitro immune function in multiple myeloma patients after high-dose chemotherapy and autologous peripheral stem cell transplantationM Lindemann, P Schuett, T Moritz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 1999
Gemcitabine as a single agent in the treatment of relapsed or refractory aggressive non-Hodgkin's lymphomaA Fosså, A Santoro, W Hiddemann, et al.
European Journal of Haematology|February 23, 2007
Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomasP Schütt, J Passon, P Ebeling, et al.
Blut|June 18, 1979
[Effect of long-term cytostatic therapy on the hematopoietic stem cells]M R Nowrousian, U W Schaefer, S Ohl, et al.
British Journal of Haematology|October 1, 1995
Homozygous loss of the MTS1/p16 and MTS2/p15 genes in lymphoma and lymphoblastic leukaemia cell linesR Siebert, C P Willers, A Schramm, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2003
Impact of chemotherapy regimen and hematopoietic growth factor on mobilization and collection of peripheral blood stem cells in cancer patientsM R Nowrousian, S Waschke, P Bojko, et al.
Pageof 5